The food allergy treatment market size was valued at USD 6.51 billion in 2024 and is expected to reach USD 12.57 billion by 2032, growing at a CAGR of 8.62% over the forecast period of 2025-2032.
The global food allergy treatment market is growing steadily, primarily due to the increasing incidence of food allergies, particularly in children, along with growing awareness and improvement in immunotherapy. Introduction of new therapies, such as oral and epicutaneous immunotherapy and epinephrine auto-injectors, is changing the treatment landscape. Increasing investments in research and development for allergies and regulatory frameworks that facilitate development activities add to the food allergy treatment market analysis.
The U.S. food allergy treatment market size was valued at USD 2.39 billion in 2024 and is expected to reach USD 4.43 billion by 2032, growing at a CAGR of 8.06% over the forecast period of 2025-2032.
Among North American countries, the U.S. has the largest share of the food allergy treatment market, due to its high food allergy prevalence, access to advanced healthcare, and the early approval of drugs, such as Palforzia. The U.S. remains the dominant market in the region, which can be credited to both favorable reimbursement policies and a continually active clinical trial landscape.
According to FARE, FARE estimates that roughly 33 million Americans have at least one food allergy. At least 1 food allergy affects around 11% of adults 18 or older. That’s over 27 million adults.
Market Dynamics:
Drivers:
Rising Prevalence of Food Allergies is Driving the Market Growth
Increased incidences of food allergies globally, particularly among children. Peanuts, tree nuts, milk, shellfish, and eggs are among the most common allergens, causing an increasing number of allergic reactions, some of which are severe and life-threatening (anaphylaxis). Part of its increasing prevalence is attributed to sedentary lifestyle, environmental, and dietary changes. With an increasing number of people diagnosed with food allergies, the need for treatment and management grows. Allergy-related emergency visits are also increasing for healthcare providers, which creates the demand for both short-term and long-term medicines.
According to NIH, Food allergies affect about 520 million people globally, where 3–10% of children and 10% of adults having a food allergy.
Advancements in Immunotherapy Accelerating the Market Growth
Immunotherapy is becoming an approach strategy that targets beyond simply addressing allergic responses, it seeks to desensitize patients to allergens and decrease their sensitivity over time. New developments, such as oral immunotherapy (OIT) and epicutaneous immunotherapy (EPIT) have proven effective in clinical trials and received regulatory approvals (Palforzia for peanut allergy). These food allergy drugs hold promise for longer-lasting allergy control by enabling patients to tolerate allergens safely. Ongoing research and development in this area, such as treatments for multiple allergens, are fueling high levels of interest and investment, positioning immunotherapy as one of the most rapidly expanding food allergy treatment market trends within the market.
Omalizumab (Xolair), approved in Feb 2024 as adjunct therapy to decrease the frequency of allergic reactions (including anaphylaxis) in patients 1 year of age and older with IgE-mediated food allergies.
Restraints:
High Treatment Costs are Restraining the Market from Growing
High expenses of genuine treatment and securing devices for the administration of responses are one of the principal restraints influencing the food allergy treatment market growth. Prolonged treatments, complex formulations, and high clinical visit frequencies, seen in most OIT and EPIT immunotherapy treatments, have considerable costs to patients and healthcare systems. However, for many families, costs can prove to be prohibitive, and access to evidence-based treatment for effective care is restricted (many low and/or middle-income countries).
According to PubMed, the recent study on probiotic peanut oral immunotherapy (PPOIT) reported that the healthcare cost per patient at 10 years was estimated to be approximately USD 9,355 (USD 6,000), with over 50% of that cost attributable to treatment delivery.
Furthermore, emergency devices with proven life-saving potential, such as epinephrine auto-injectors (EpiPen), are high-priced, essential treatments to be used in case of anaphylactic reactions. Health insurance coverage for such devices is highly variable between countries, regions, and insurers, and disposable copayments can be excessive. The cost associated with these drugs typically results in patients postponing treatment or opting for non-optimal solutions, limiting the growth of the market and implementation of new therapies.
By Allergen Type
The peanuts segment dominated the food allergy treatment market in 2024 with 22.5% market share, owing to the widespread and severe nature of peanut allergies, especially in children from developed regions, such as North America and Europe. Allergic reactions to peanuts are typically permanent, and even small amounts can cause serious, life-threatening reactions, including anaphylaxis. Consequently, this has led to high demand for the focus of the treatments, such as epinephrine auto-injectors, as well as oral immunotherapy solutions, including Palforzia, the first FDA Green-lighted therapy for the peanut allergy treatment.
The tree nuts segment is projected to exhibit significant growth over the forecast period in the market, due to the increasing prevalence and high clinical interest in management of multiple nut allergies. Tree nuts, including almonds, cashew nuts, and walnuts, are high up on the list of major allergens that cause severe allergic reactions and are common in conjunction with peanut allergies. The segment is poised to benefit from developments in research and the advancement of new immunotherapy treatment options for access to multiple allergen targets, with tree nuts taking the lead in diagnosis and targeted therapies. Moreover, the rise in awareness, along with food labeling regulations and increasing investment in R&D for broader allergen-specific therapies, is expected to drive this segment during the forecast period.
By Drug Type
The food allergy treatment market was dominated by the epinephrine segment in 2024, with a 42.11% market share, as it is the first-line emergency treatment of choice in case of severe allergic reactions, such as anaphylaxis. Auto-injectors of epinephrine (EpiPen) are the most commonly prescribed and most carried devices for patients with known food allergies, affording rapid rescue from life-threatening situations. Epinephrine has remained the cornerstone of allergy treatment due to its potency, robustness, and track record for clinical use. Increased awareness programs, nearby college safety regulations that require auto-injectors on site, and insurance schemes support the segment's dominance, especially in the developed regions.
The immunotherapy segment is anticipated to grow at the fastest rate during the forecast period due to the increasing demand for preventive and long-term treatments. While epinephrine is used for the management of acute reactions, immunotherapy (both oral immunotherapy [OIT] and epicutaneous immunotherapy [EPIT]) is one of the clinical approaches that aims to desensitize patients to allergens and leads to reactivity-cauterization in the long term.
The parenteral segment dominated the food allergy treatment market share in 2024, owing to the intramuscular route to the panoply of epinephrine auto-injectors that are utilized in the market to mitigate the vast arena of allergic reactions, including anaphylaxis. The parenteral route is the fastest, which results in many emergencies that require immediate intervention. This perfect clinical paradigm for the indication for parenteral usage in conjunction with high epinephrine prescription rates in the developed markets. Furthermore, the rise of user-friendly devices and improved knowledge about the need for them in allergy management have made this route nationalization proven as an efficient path.
The oral segment is anticipated to exhibit the fastest growth over the forecast period, owing to the rising usage of oral immunotherapy (OIT) as a durable food allergy treatment. Immunotherapy consists of a long-term, gradual, and controlled introduction of allergens that activate the immune system to create tolerance against the respective allergen and assumes a progressive decrease in allergic sensitization. This approach has been validated by the FDA approval of Palforzia for peanut allergy and has generated tremendous clinical and commercial interest. As research continues to broaden the potential for OIT (including new allergens) and physicians find patients are preferring non-invasive home-based approaches to treatment, the oral route is becoming the method of choice for the future of allergy therapy.
By End Use
In 2024, the hospital pharmacies segment dominated the food allergy treatment market, as hospitals are a substantial medium of action for serious allergy management and emergency care. In an acute care setting, hospital pharmacies are well equipped to dispense life-saving medications, such as epinephrine and antihistamines. They provide a wide range of specialized treatments and are also involved in providing parenteral medications that require clinical supervision.
The retail pharmacies segment is projected to witness the fastest growth during the forecast period due to profit from patients seeking integrated and fast relief allergy therapy. With the growing awareness of food allergies, many patients are more likely to ask for maintenance medications, epinephrine auto-injectors, and antihistamines, all of which are to be accessed at a retail pharmacy without problems. They provide counseling services, medication management, and broader geographic reach for the chains, particularly in suburban and rural markets.
North America dominated the food allergy treatment market with around 40.7% market share in 2024, owing to advanced healthcare infrastructures, a high level of awareness among payers, healthcare providers, and patients in the region, along with quick and early approvals for innovative therapies that can be used to treat food allergies. In the U.S., the path has been paved with the first oral immunotherapy for peanut allergy, Palforzia, receiving FDA approval, and epinephrine auto-injectors, such as EpiPen. The ubiquity of innovative treatment approaches is driven by strong research funding and general allergy screening, as well as favorable reimbursement policies.
According to NCBI, nearly 32 million Americans (almost 10% of the US population) have food allergies, including almost 6 million children. Self-reported allergy surveys in Canada show that around 7% of the population reports they have at least 1 food allergy.
Asia Pacific is the fastest-growing region with a 9.30% CAGR due to increasing urbanization, westernization of dietary patterns, and a surge in the population of food allergies among individuals. China, Japan, and India are some of the few countries driving the market. Food allergy has long been underdiagnosed in the region, but is increasingly coming into the public health spotlight against a backdrop of policy initiatives to raise awareness among practitioners. The market expansion is attributed to advancements in diagnostics, an increase in healthcare expenditure, and a slow diffusion of immunotherapy.
The food allergy treatment market in the European region is projected to experience significant growth with huge development due to high awareness about food allergies, improved diagnostic abilities, and a higher quantity of clinical trial population in the region. The U.K., Germany, and France lead the way, backed by robust regulatory frameworks and health systems that are assimilating food allergen management more holistically. In this regard, rising use of immunotherapy, comprising oral and epicutaneous immunotherapy, together with the availability of emergency medication, such as epinephrine auto-injectors, are some of the factors reflecting a positive impact on market growth.
Moreover, public health initiatives, such as allergen labeling, food safety, and school-based allergy management programs, are increasing the need for early identification and treatment. In Europe, there are influential collaborations between the academic institutions, the biotech firms, and regulatory bodies that are also accelerating the development of new therapies and getting them approved in both continents. Europe is a key player in the food allergy treatment landscape and is increasingly making its mark on the global arena in line with FP awareness and diagnosis rate increases.
Latin America and the Middle East & Africa (MEA) hold a moderate share in the food allergy treatment market that is likely to grow at a moderate rate, owing to increasing awareness and gradual improvement in health infrastructure. The lack of availability of specialized allergy care, underdiagnosis, and the uneven distribution of other medical resources in rural areas and resource-rich urban areas prevent fast market growth. Despite that, expanding investments in health care and educational campaigns about food sensitivity are helping sustain steady market development.
Food allergy awareness is gradually emerging in the MEA region, most notably in the wealthier Gulf countries, such as the UAE and Saudi Arabia, where healthcare modernization is moving quickly. However, the area continues to struggle with insufficient numbers of trained allergists, poor access to advanced treatments, such as immunotherapy, and low diagnoses overall. That being said, the market is anticipated to experience growth owing to rising health awareness, urbanization, and increasing emphasis on food safety and pediatric care.
Key Market Players:
Food allergy treatment companies are Aimmune Therapeutics, DBV Technologies, ALK-Abelló, Stallergenes Greer, Camallergy, Alladapt Immunotherapeutics, Aravax, Intrommune Therapeutics, Prota Therapeutics, Regeneron Pharmaceuticals, and other players.
January 2025 – DBV Technologies, a clinical-stage biopharmaceutical company, reported positive 24-month data from the Open-Label Extension (OLE) of its Phase 3 EPITOPE trial assessing VIASKIN Peanut 250 µg (VP250) in children aged 1 to 3 years. The results show that sustained treatment with VIASKIN Peanut showed continued improvement in all efficacy measures through 36 months of therapy.
June 2024 – ALK-Abelló launched its new corporate strategy, Allergy+, and its financial targets for 2028. Allergy+ is ALK's strategy to increase its leadership in allergy immunotherapy by creating a leading position in the food allergy and anaphylaxis treatment market, in addition to pushing innovation into adjacent allergic diseases with high unmet medical needs.
|
Report Attributes |
Details |
|---|---|
|
Market Size in 2024 |
USD 6.51 Billion |
|
Market Size by 2032 |
USD 12.57 Billion |
|
CAGR |
CAGR of 8.62% From 2025 to 2032 |
|
Base Year |
2024 |
|
Forecast Period |
2025-2032 |
|
Historical Data |
2021-2023 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
• By Allergen Type (Dairy Products, Poultry Products, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other) |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
|
Company Profiles |
Aimmune Therapeutics, DBV Technologies, ALK-Abelló, Stallergenes Greer, Camallergy, Alladapt Immunotherapeutics, Aravax, Intrommune Therapeutics, Prota Therapeutics, Regeneron Pharmaceuticals, and other players. |
Ans: The Food Allergy Treatment Market is expected to grow at a CAGR of 8.62% from 2025 to 2032.
Ans: The Food Allergy Treatment Market was USD 6.51 billion in 2024 and is expected to reach USD 12.57 billion by 2032.
Ans: Rising prevalence of food allergies is driving the market growth.
Ans: The “Epinephrine” segment dominated the Food Allergy Treatment Market.
Ans: North America dominated the Food Allergy Treatment Market in 2024.
Table Of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Prevalence and Incidence of Food Allergies (2024)
5.2 Prescription Trends (2024), by Region
5.3 Healthcare Spending on Food Allergy Treatments (2024), by Region
5.4 Regulatory and Reimbursement Trends
5.5 Clinical Trials and R&D Activity (Ongoing and Pipeline Therapies)
6. Competitive Landscape
6.1 List of Major Companies By Region
6.2 Market Share Analysis By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Food Allergy Treatment Market Segmentation By Allergen Type
7.1 Chapter Overview
7.2 Dairy Products
7.2.1 Dairy Products Market Trends Analysis (2021-2032)
7.2.2 Dairy Products Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Poultry Product
7.3.1 Poultry Product Market Trends Analysis (2021-2032)
7.3.2 Poultry Product Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Tree Nuts
7.4.1 Tree Nuts Market Trends Analysis (2021-2032)
7.4.2 Tree Nuts Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Peanuts
7.5.1 Peanuts Market Trends Analysis (2021-2032)
7.5.2 Peanuts Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Shellfish
7.6.1 Shellfish Market Trends Analysis (2021-2032)
7.6.2 Shellfish Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Wheat
7.7.1 Wheat Market Trends Analysis (2021-2032)
7.7.2 Wheat Market Size Estimates and Forecasts to 2032 (USD Billion)
7.8 Soys
7.8.1 Soy Market Trends Analysis (2021-2032)
7.8.2 Soy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.9 Other
7.9.1 Other Market Trends Analysis (2021-2032)
7.9.2 Other Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Food Allergy Treatment Market Segmentation By Drug Type
8.1 Chapter Overview
8.2 Antihistamines
8.2.1 Antihistamines Market Trends Analysis (2021-2032)
8.2.2 Antihistamines Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Epinephrine
8.3.1 Epinephrine Market Trends Analysis (2021-2032)
8.3.2 Epinephrine Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Immunotherapy
8.4.1 Immunotherapy Market Trends Analysis (2021-2032)
8.4.2 Immunotherapy Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Food Allergy Treatment Market Segmentation By Route of Administration
9.1 Chapter Overview
9.2 Parenteral
9.2.1 Parenteral Market Trends Analysis (2021-2032)
9.2.2 Parenteral Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Oral
9.3.1 Oral Market Trends Analysis (2021-2032)
9.3.2 Oral Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Topical
9.4.1 Topical Market Trends Analysis (2021-2032)
9.4.2 Topical Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Food Allergy Treatment Market Segmentation by End-User
10.1 Chapter Overview
10.2 Hospital Pharmacies
10.2.1 Hospital Pharmacies Market Trends Analysis (2021-2032)
10.2.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Retail Pharmacies
10.3.1 Retail Pharmacies Market Trend Analysis (2021-2032)
10.3.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Others
10.4.1 Other Market Trends Analysis (2021-2032)
10.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trend Analysis
11.2.2 North America Food Allergy Treatment Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.2.3 North America Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.2.4 North America Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.2.5 North America Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.2.6 North America Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.2.7.2 USA Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.2.7.3 USA Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.2.7.4 USA Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.2.8.2 Canada Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.2.8.3 Canada Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.2.8.4 Canada Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.2.9.2 Mexico Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.2.9.3 Mexico Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.2.9.4 Mexico Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3 Europe
11.3.1 Trend Analysis
11.3.2 Europe Food Allergy Treatment Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.3.3 Europe Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.4 Europe Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.5 Europe Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.6 Europe Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.7 Germany
11.3.7.1 Germany Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.7.2 Germany Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.7.3 Germany Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.7.4 Germany Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.8 France
11.3.8.1 France Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.8.2 France Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.8.3 France Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.8.4 France Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.9 UK
11.3.9.1 UK Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.9.2 UK Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.9.3 UK Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.9.4 UK Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.10 Italy
11.3.10.1 Italy Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.10.2 Italy Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.10.3 Italy Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.10.4 Italy Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.11 Spain
11.3.11.1 Spain Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.11.2 Spain Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.11.3 Spain Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.11.4 Spain Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.12 Poland
11.3.12.1 Poland Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.12.2 Poland Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.12.3 Poland Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.12.4 Poland Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.13 Turkey
11.3.13.1 Turkey Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.13.2 Turkey Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.13.3 Turkey Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.13.4 Turkey Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.14 Rest of Europe
11.3.14.1 Rest of Europe Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.3.14.2 Rest of Europe Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.3.14.3 Rest of Europe Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.3.14.4 Rest of Europe Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trend Analysis
11.4.2 Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.4.3 Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.4 Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.5 Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.6 Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.7.2 China Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.7.3 China Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.7.4 China Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.8.2 India Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.8.3 India Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.8.4 India Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.9.2 Japan Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.9.3 Japan Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.9.4 Japan Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.10.2 South Korea Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.10.3 South Korea Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.10.4 South Korea Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.11 Singapore
11.4.11.1 Singapore Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.11.2 Singapore Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.11.3 Singapore Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.11.4 Singapore Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.12 Australia
11.4.12.1 Australia Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.12.2 Australia Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.12.3 Australia Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.12.4 Australia Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.13 Rest of Asia Pacific
11.4.13.1 Rest of Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.4.13.2 Rest of Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.4.13.3 Rest of Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.4.13.4 Rest of Asia Pacific Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Trend Analysis
11.5.2 Middle East and Africa Food Allergy Treatment Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.5.3 Middle East and Africa Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.5.4 Middle East and Africa Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.5.5 Middle East and Africa Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.5.6 Middle East and Africa Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.7 UAE
11.5.7.1 UAE Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.5.7.2 UAE Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.5.7.3 UAE Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.5.7.4 UAE Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.8 Saudi Arabia
11.5.8.1 Saudi Arabia Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.5.8.2 Saudi Arabia Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.5.8.3 Saudi Arabia Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.5.8.4 Saudi Arabia Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.9 Qatar
11.5.9.1 Qatar Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.5.9.2 Qatar Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.5.9.3 Qatar Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.5.1.9.4 Qatar Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.10 South Africa
11.5.10.1 South Africa Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.5.10.2 South Africa Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.5.10.3 South Africa Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.5.10.4 South Africa Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.11 Rest of Middle East & Africa
11.5.11.1 Rest of Middle East & Africa Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.5.11.2 Rest of Middle East & Africa Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.5.11.3 Rest of Middle East & Africa Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.5.11.4 Rest of Middle East & Africa Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6 Latin America
11.6.1 Trend Analysis
11.6.2 Latin America Food Allergy Treatment Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.6.3 Latin America Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.6.4 Latin America Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.6.5 Latin America Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.6.6 Latin America Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.6.7.2 Brazil Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.6.7.3 Brazil Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.6.7.4 Brazil Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.6.8.2 Argentina Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.6.8.3 Argentina Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.6.8.4 Argentina Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6.9 Rest of Latin America
11.6.9.1 Rest of Latin America Food Allergy Treatment Market Estimates and Forecasts by Allergen Type (2021-2032) (USD Billion)
11.6.9.2 Rest of Latin America Food Allergy Treatment Market Estimates and Forecasts by Drug Type (2021-2032) (USD Billion)
11.6.9.3 Rest of Latin America Food Allergy Treatment Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)
11.6.9.4 Rest of Latin America Food Allergy Treatment Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
12. Company Profiles
12.1 Aimmune Therapeutics
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 DBV Technologies
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 ALK-Abelló
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Stallergenes Greer
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Camallergy
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Alladapt Immunotherapeutics
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Aravax,
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Intrommune Therapeutics
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Prota Therapeutics
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Regeneron Pharmaceuticals
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Allergen Type
By Drug Type
By Route of Administration
By End Use
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/sample-request/7288
Regional Coverage:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Country Level Research Report: https://www.snsinsider.com/sample-request/7288
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
